International Scholarly Research Notices / 2014 / Article / Tab 1 / Research Article
p16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi Table 1 Patient clinical characteristics, including age, gender, location of tumor, and follow-up data.
Diagnosis Age Sex Location Clinical follow-up Benign CBN 21 F Arm N/A Mildly atypical CBN 32 F Leg N/A Mildly atypical CBN 24 M Arm N/A Mildly atypical CBN 63 M Arm N/A Mildly atypical CBN 28 F Scalp N/A Mildly atypical CBN 87 M Ear N/A Moderately atypical CBN 35 M Scalp N/A Moderately atypical CBN 78 F Face N/A Moderately atypical CBN 51 F Buttock N/A Moderately atypical CBN 25 M Leg N/A Severely atypical CBN 49 F Back No recurrence after 21 months Severely atypical CBN 51 F Leg No follow-up since diagnosis Severely atypical CBN 23 M Chest Lost to follow-up Severely atypical CBN 38 F Buttock Lost to follow-up Severely atypical CBN 57 F Buttock No follow-up since diagnosis Superficial spreading melanoma 59 M Back No recurrence after 24 months Superficial spreading melanoma 68 F Arm No recurrence after 20 months Melanoma in transit metastasis 83 F Arm Metastatic disease Spitzoid melanoma 24 F Chest No recurrence after 12 months Melanoma in situ 54 M Toe No recurrence after 22 months Superficial spreading melanoma 32 M Back No recurrence after 16 months Superficial spreading melanoma 60 M Back Lost to follow-up Superficial spreading melanoma 73 M Neck No recurrence after 18 months Nevoid melanoma 56 F Back Lost to follow-up Superficial spreading melanoma 22 F Leg No recurrence after 16 months Spitzoid melanoma 41 M Back No recurrence after 22 months Superficial spreading melanoma 23 F Arm No recurrence after 11 months Malignant CBN 61 F Foot No recurrence after 12 months Malignant CBN 13 M Face No follow-up since diagnosis Malignant CBN 86 M Back In transit metastasis Malignant CBN recurrence 66 M Face N/A